article thumbnail

Our healthcare system is really screwed up

World of DTC Marketing

A 2015 Commonwealth Fund brie f showed that — before the major provisions of the Affordable Care Act were introduced — the United States had worse outcomes and spent more on health care, primarily because of greater use of medical technology and higher prices, compared to other high-income countries. This IS the future of healthcare.

article thumbnail

Value-Based healthcare won’t work

World of DTC Marketing

SUMMARY: Value-based healthcare is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes. In a country where people really don’t care of themselves value-based healthcare won’t work. IPoor health is also associated with an increase in cancers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

At JPM, Top GSK Cancer Executive Talks Drug Targets and Oncology Strategy

MedCity News

Though GSK divested much of its oncology assets to Novartis in 2015, the company has built it back through a internal R&D and business development deals. Morgan Healthcare Conference in San Francisco.

article thumbnail

Top 12 Healthcare Technology Start-ups To Know

Medico Reach

The healthcare sector has seen a few developments over the years. Founder: Eric Lefkofsky Year of establishment: 2015 Headquarters: Chicago, Illinois. Tempus began with the goal of incorporating artificial intelligence and data science into the healthcare industry. Wondering what that is? billion in 2022. Let’s get into it!

article thumbnail

AI in healthcare: From buzzword to boardroom

Clarify Health

Generative AI: The New Frontier in Healthcare Technology Healthcare Unbound episode recap: We know that AI is a transformative technology already reshaping almost every kind of business, and healthcare is no exception. But what does the future of AI in healthcare look like?

article thumbnail

Biosimilar competition saves US healthcare $21 billion

European Pharmaceutical Review

Amgen’s 2022 market report has detailed how competition has driven savings across healthcare, estimating that a considerable number of biologics will be in competition with biosimilars in five to 10 years. More interchangeable biosimilars are estimated to be approved and launched in the US in the next few years.

article thumbnail

The White House Climate Pledge: Why Sustainability Makes Good Business Sense in Healthcare

PM360

The White House’s recent Health Sector Climate Pledge brought together hospitals and healthcare companies that committed to reduce greenhouse gas emissions 50% by 2030. The social, economic, and environmental impact of such initiatives are clear, but only a few companies in the healthcare industry have made this kind of commitment so far.